Equashield a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced that it will be leading a symposium exploring the use of robotics in cytotoxic drug handling at the International Symposium on Oncology Pharmacy Practice (ISOPP).
The symposium will introduce the Equashield Pro, the first drug compounding robot utilizing Equashield’s proprietary CSTD technology. It will also discuss the role that the Equashield Pro will play in increasing pharmacy throughput while simultaneously keeping pharmacists safe.
The symposium will feature presentations from leading industry experts. Equashield’s symposium will also include an augmented reality demonstration of the Equashield Pro robot.
Utilizing advanced robotic technologies, the Equashield Pro enables quick compounding of a large variety of patient specific chemotherapy doses using a method that shortens the process flow while performing multiple simultaneous tasks. Comparable in size to a standard Biological Safety Cabinet, it is easily integrated into hospital pharmacies, while dose verification software protects against cases of medication dosage and identification errors.